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ABSTRACT
Introduction Adolescents represent one of the most 
underserved population groups among people living with 
HIV. With successes in the elimination of mother to child 
transmission initiatives and advances in paediatric HIV 
treatment programmes, a large population of HIV- infected 
children are surviving into adolescence. Adolescence 
presents unique challenges that increase the risk of 
non- suppressed viral loads in adolescents living with HIV 
(ALHIV). There is a need to develop, implement and test 
interventions to improve viral suppression among ALHIV. 
Systematic reviews of recent studies present scarce 
and inconclusive evidence of effectiveness of current 
interventions, especially for adolescents. This protocol 
provides a description of a planned review of interventions 
to improve treatment outcomes among unsuppressed 
ALHIV.
Methods and analysis A comprehensive search string 
will be used to search six bibliographic databases: 
PubMed/MEDLINE, Sabinet, EBSCOhost, CINAHL, Scopus 
and ScienceDirect, for relevant studies published between 
2010 and 2020 globally, and grey literature. Identified 
articles will be exported into Mendeley Reference 
Management software and two independent reviewers will 
screen the titles, abstracts and full texts for eligibility. A 
third reviewer will resolve any discrepancies between the 
two initial reviewers. Studies reporting on interventions 
to improve viral suppression, retention and adherence 
for adolescents will be considered for inclusion. The 
systematic review will be performed and reported 
according to the Preferred Reporting Items for Systematic 
Reviews and Meta- Analyses Protocols. Where feasible, a 
meta- analysis will be conducted using Stata Statistical 
Software: Release V.16. The quality of the studies and risk 
of bias will be assessed using the Critical Appraisal Skills 
Programme checklists and Risk of Bias in Non- randomised 
Studies of Interventions tool, respectively.
Ethics and dissemination The systematic review entails 
abstracting and reviewing already publicly available data 
rather than any involvement of participants, therefore, no 
ethical clearance will be required. Results will be shared 
with relevant policy- makers, programme managers and 
service providers, and published and share through 
conferences and webinars.
PROSPERO registration number CRD42021232440.
INTRODUCTION
Along with the successes in elimination 
of mother- to- child transmission initiatives 
worldwide and developments in paediatric 
HIV treatment, more children with HIV 
are surviving to reach adolescence.1 Inno-
vations for early infant diagnosis, such as 
point- of- care diagnostics and prompt initi-
ation of life- saving HIV treatment, have 
meant a large population of perinatally HIV- 
infected children are growing into adoles-
cence.2 A mixed adolescent population 
exists consisting of perinatally infected and 
behaviourally infected adolescents living with 
HIV (ALHIV) who may respond to inter-
ventions differently.3 Worldwide, 1.6 million 
adolescents aged 10–19 years were estimated 
to be living with HIV in 2018; with approxi-
mately 85% residing in sub- Saharan Africa.4 5 
WHO defines adolescents as individuals aged 
between 10 and 19 years.6 The proposed 
systematic review seeks to look at literature on 
both perinatally and behaviourally infected 
adolescents, aged 10–19 years. Although data 
Strengths and limitations of this study
 ► This review contributes to the available knowledge 
on evaluated interventions targeting adolescents 
with unsuppressed viral loads that could inform 
adolescent- friendly HIV services guidelines in both 
health facilities and community settings.
 ► This protocol uses the standardised Preferred 
Reporting Items for Systematic Reviews and Meta- 
Analyses Protocols 2015 guidelines.
 ► The search strategy uses six major electronic data-
bases which will include peer- reviewed articles and 
grey literature.
 ► A potential limitation of this study includes the lim-
itation to studies published in English language only, 
which has the potential to miss other relevant stud-
ies published in other languages.
 ► The study limitations may be associated with the 
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on HIV treatment among adolescents are scarce, access 
and uptake of comprehensive care and treatment pack-
ages among this vulnerable population group is report-
edly lower than adults.7 In 2019, only 53% (36%–64%) 
of children aged 0–14 years were accessing treatment 
as compared with 68% (54%–80%) coverage among 
15 years and older individuals living with HIV.8 In the 
majority of sub- Saharan Africa countries, public sector 
health settings are ill equipped to provide guidance and 
adequate support for ALHIV to stay engaged in HIV care 
and adhere to treatment regimens.9
Good adherence to treatment regimens and consis-
tent engagement in HIV care is essential for achieving 
sustained viral suppression, which is vital for ensuring the 
well- being of ALHIV and reducing chances of onward 
HIV transmission.10 Poor adherence to antiretrovirals 
increases the risk of emergence of drug resistance muta-
tions, reduces treatment efficacy, thereby advancing 
disease progression and reducing future treatment 
options and increasing the risk of further transmission 
driven by unsuppressed viral loads.11 Despite reportedly 
high levels of adherence to antiretroviral therapy (ART) 
globally (>95%), diminishing adherence levels over time 
remains a concern, primarily the loss of patients during 
scaling up of HIV programmes.12 Evidence- based strat-
egies to mitigate adherence challenges for individuals 
on HIV treatment include facility and community- based 
interventions, which includes individual or group adher-
ence counselling, pharmacist counselling and medication 
fast- tracking, mHealth, home- based/community- based 
strategies, financial incentives, nutritional support, moti-
vational interviewing and awarding of disability grants.13 
Individual counselling, peer- led support groups and 
different models of group adherence counselling inter-
ventions, such as teen clubs, are the most common inter-
ventions for ALHIV.
Adolescents receiving HIV treatment have distinct and 
unique needs and are notably underserved worldwide in 
national HIV responses. Ultimately, this negatively affects 
access to ART for adolescents, and results in subop-
timal ART adherence and poorer treatment outcomes 
including achieving sustained viral suppression.14 WHO 
defines viral suppression as a maintained viral load count 
of less than 1000 RNA copies/mL of plasma.15 However, 
recent debates have suggested reducing the suppression 
threshold to 200 copies/mL, informed by evidence from 
HPTN 052 findings, PARTNERS and Opposites Attract, 
who all reported that successful ART with viral suppres-
sion prevented transmission when viral load was unde-
tectable below 200 copies/mL.16 Variations in viral load 
assay limit of detection has also been tied to the debates 
around threshold setting for viral load suppression, and 
these need to be paid attention to in any evaluation.
A systematic review conducted in 2014 estimated global 
ART adherence levels ranging between 16% and 99% 
among adolescents and a meta- analysis of data repre-
senting adolescents and young adults between 12 and 
24 years found a pooled adherence estimate of 84% in 
53 Asian and African countries. Viral suppression (cut- 
off <400 copies/mL) rates were between 52% and 87% in 
Asia, 27% and 89% in Africa, and between 37.5% and 49% 
in Central and South America.17 A 2018 systematic review 
of 11 studies on factors impacting ART adherence among 
HIV positive adolescents in sub- Saharan Africa reported 
a complex web of 29 facilitators and 44 barriers among 
adolescents. These factors include stigma, forgetfulness, 
ART side effects and lack of assistance as main barriers, 
while knowledge of status, caregiver support and peer 
support groups were the dominant facilitators.18 Other 
barriers and facilitators of treatment adherence among 
adolescents in countries in the global south have been 
noted as family support, a heavy pill burden/treatment 
regimen, attitudes towards medication and various health 
delivery system factors.19 Often these studies reported 
on adherence only using self- report or pill counts, with 
no viral load results reported. Self- reported adherence 
is mostly challenging, especially in adolescents, as clearly 
demonstrated in Pre- Exposure Prophylaxis (PrEP) studies 
where there was no correlation between therapeutic 
drug monitoring and self- report especially in younger 
populations.20
Despite recent increased focus and several systematic 
reviews synthesising interventions to improve treatment 
outcomes among adolescents, we could not find reviews 
specifically focusing on studies targeting unsuppressed 
adolescents. Although our focus is predominantly on 
viral suppression, broader outcomes such as adherence 
and retention in care will be considered. Previous reviews 
have identified specific types of interventions that show 
promise for improved adherence to ART and retention 
in HIV care with very limited quantity of studies and 
low quality in several studies focusing on adolescents 
aged 10–19 years published up until 2015.21 A review by 
MacPherson et al focused on studies published between 
2001 and 2014 evaluating effectiveness of interventions 
on service delivery to improve linkage to treatment initi-
ation, retention in HIV care and ART adherence among 
ALHIV aged 10–19 years.14 Considering that only 11 
studies were included in the study, with low- to- moderate 
methodological quality, from high- income countries and 
none from countries with a generalised HIV epidemic, 
the authors suggested further investigations on their find-
ings which included promising results from individual 
and group education and counselling, increased acces-
sibility to clinics, youth- friendly services and financial 
incentives.14
Casale et al reviewed studies published between January 
2016 and June 2018, and provided an update on evidence 
from empirical evaluations on interventions designed to 
enhance ART adherence and retention in care for adoles-
cents aged 10–19 years and youth aged 15–24 years living 
with HIV.21 The authors reported on 10 relevant studies, 
mostly from sub- Saharan Africa, using six clinic- level 
interventions, three community- level or household- level 
intervention, and one mHealth trial at individual level, 
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development and testing of multifaceted interventions 
over and above facility- based interventions, that address 
broader socioeconomic barriers, prioritising adolescents 
aged 10–19 years, if we are to address the treatment gap 
among this population group.21 A more recent review of 
studies published from September 2015 to January 2019 
by Lindsey et al reported that ART adherence interven-
tions for adolescents and youth implemented in low- and 
middle- income countries showed mixed results from 
interventions at patient- level and health services level, 
with none of the interventions improving treatment 
adherence or virologic suppression.22 The authors argued 
that intensive home- based case management approaches 
to care hold much promise in improving treatment 
outcomes in adolescents and youth and warrant further 
research.22 Most recent published studies focusing on 
interventions such as Enhanced Adherence Counselling 
and Community Adolescent Treatment Supporters to 
improve treatment outcomes among ALHIV challenged 
with viral suppression and retention in care may provide 
new evidence for consideration.23–25
RATIONALE FOR THE REVIEW
Globally, it is apparent that there has been an increased 
focus in addressing the treatment gap among ALHIV, and 
in recent years, there have been a number of systematic 
reviews focusing on interventions to improve ART adher-
ence and retention in HIV care among adolescents and 
young adults in general. While the gaps described above 
and the systematic reviews cited present opportunities and 
specific interventions that show promise, they also high-
light the limited quantity and low- to- moderate quality of 
studies and evidence on interventions targeting ALHIV. 
These reviews commonly include interventions for all 
adolescents and youth, despite their viral load suppres-
sion levels, which include clinic- level interventions, 
individual- level and community- level or household- level 
interventions. Considering the urgent need to design, 
implement and test interventions to keep adolescents in 
care and achieve and maintain viral load suppression, we 
propose to review studies that specifically evaluated inter-
ventions targeting adolescents challenged with staying 
engaged in care and maintaining viral suppression. This 
review will focus on adolescents experiencing poor treat-
ment outcomes to provide an updated data synthesis of 
all adherence and retention interventions to close the 
treatment gap. We aim to broaden the synthesised knowl-
edge base to include new and innovative interventions for 
this particular population, at health facility, community 
and household levels, and potentially reinforce or modify 
already existing promising interventions for achievement 
of sustained viral suppression.
METHODS
This systematic review will use the seven steps as set out 
by Eggar and Smith.26 The seven steps are outlined as 
(1) formulate the review question; (2) define the inclu-
sion and exclusion criteria; (3) develop a search strategy; 
(4) study selection; (5) assess the quality of studies; (6) 
extract data and (7) analyse or synthesise the data.
REVIEW QUESTION
The following questions will guide the review of the liter-
ature published between 2010 and 2020:
1. What interventions are being implemented to improve 
treatment outcomes for adolescents on ART with chal-
lenges suppressing their viral load?
2. How effective have the interventions been in achieving 
better treatment outcomes among adolescents on ART 
with challenges suppressing their viral load?
INCLUSION AND EXCLUSION CRITERIA
The literature search will be guided by the following 
inclusion criteria:
1. Published studies in peer- reviewed journals and grey 
literature.
2. The study population includes ALHIV aged 10–19 
years, both perinatally and behaviourally infected ad-
olescents included.
3. Reported the association between the intervention, 
and viral suppression, retention and adherence.
4. Reported comparisons in quantitative measures of vi-
ral suppression, retention and adherence, including 
prearm/postarm or multiarm comparison groups.
5. Study outcomes include viral suppression, retention and 
ART adherence.
6. Studies published in English language.
7. Studies from all countries, high- income, middle- 
income and low- income settings, published between 
2010 and 2020.
The Population/Patient/Problem, Intervention, 
Comparison, Outcome and Time (PICOT)- based inclu-
sion criteria has been summarised in table 1. Studies that 
are not available in English language will be excluded, as 
well as review papers, editorials and letters.
The decision to only include studies reported in English 
language was necessitated by the limitations in capacity 
and resources among the review team, which restricts 
the review to English language only. Studies may include 
younger children below 10 years or young adults over 
19 years, and justification for inclusion will be provided 
if these are included in the analysis. Additionally, other 
studies may focus on adherence interventions and viral 
load suppression for all people living with HIV, including 
adolescents in the study population or sample. Age disag-
gregation will be performed where there are age overlaps 
and the authors have provided age- disaggregated data.
OUTCOME MEASURES
Viral load suppression: although WHO viral load suppres-
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may have used lower levels of viral load counts to define 
viral load suppression or disaggregate low level viraemia 
and suppression. All definitions of viral load suppression 
will be considered in this review. Where different cut- offs 
for viral load suppression are used, we will run sensitivity 
analyses.
ART adherence: adherence can be measured using 
pill counts, pharmacy refill data, self- reporting, as well as 
physician/nurse assessments and appointment keeping. 
Self- report is a common measure of adherence although 
there are concerns about its validity (limitation in correla-
tion to viral loads), and socially desirable responses from 
especially younger individuals may overestimate adher-
ence.27 More robust measures such as Medical Events 
Monitoring System and other new technologies will all 
be considered in this review. Optimal adherence will be 
considered to be at ≥95% of prescribed medication doses 
taken per specified period.
Retention in HIV care: approaches to evaluating reten-
tion in HIV care may be determined from missed clinic 
appointments or based on kept clinic visits. Retention 
variables may also include interruption in treatment, 
lost to follow- up, transferred- out or died. A subanalysis 
of the different categories of adolescents who are not 
still engaged in care will be performed if possible (when 
different retention variables are reported).
SEARCH STRATEGY FOR IDENTIFICATION OF STUDIES
The search strategy was developed with the assistance of 
the faculty librarian who will provide further guidance 
and advice in conducting the searches for the review. A 
comprehensive database search of literature reporting on 
treatment interventions and viral load suppression will be 
systematically conducted in six major databases: PubMed/
MEDLINE, Sabinet, EBSCOhost, CINAHL, Scopus and 
ScienceDirect. Grey literature searches will be performed 
on OpenGrey, Grey Literature report, International AIDS 
Conference abstract archive, and HIV and Adolescence. 
We will search the identified databases for all articles 
published between 2010 and 2020 that meet the speci-
fied selection criteria. The search syntax will first be used 
to perform a database search on PubMed/MEDLINE to 
test and optimise the strategy, which will subsequently be 
replicated and adapted as needed for the other database 
searches. Full- text articles will be sourced using a list of 
key words and terms for the search strategy using the 
“AND” and “OR” Boolean operators as appropriate. The 
search terms will include “Adolescents”, “antiretroviral 
therapy”, “retention”, “adherence”, “viral load”, “suppres-
sion”, “unsuppressed”. The search strategies used for the 
selected databases are provided in online supplemental 
material, titled “ALL Database search Results”.
STUDY SELECTION
Studies will be included in this systematic review according 
to the PICOT mnemonics. We will also consider studies 
done using quantitative or mixed methods, with a world-
wide search without any particular geographical loca-
tion limitations. Restricting reviews to a particular study 
design, such as randomised controlled trial (RCTs) only, 
may restrict findings to effectiveness only rather than 
seeking answers to more complex phenomena such as 
why an intervention may or may not be effective.28
The selection, screening and reporting of this review 
will be done in accordance with the reporting guidance 
provided in the Preferred Reporting Items for System-
atic Reviews and Meta- Analyses (PRISMA) Protocol 
2015 guidelines.29 Selected studies will be collated and 
exported into Mendeley Reference Management Soft-
ware, which will be used to manage the citations and 
recording the number of hits for each article from all 
databases, as well as removing duplicate records.30 Two 
reviewers will independently review titles and abstracts 
of all articles retrieved to assess eligibility for inclusion. 
Table 1 PICOT- based inclusion criteria
Patient 
population
Adolescents aged 10–19 years living with HIV, acquired perinatally or behaviourally, with challenges 
suppressing their viral load
Interventions Any group- based or individual- level interventions to improve treatment outcomes targeting adolescents who 
have challenges suppressing their viral loads, including differentiated service delivery models (at facility- 
based, community- based or home- based levels)
Comparisons Studies may report comparisons on quantitative measures of retention, adherence and viral load suppression 
between intervention and standard care (prerm/postarm or multiarm comparison groups)
Outcomes Primary outcome—viral load suppression





  Study designs: quantitative and mixed methods
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The two reviewers will further review full texts of the 
selected articles independently, to establish compliance 
with the eligibility criteria for inclusion in the final assess-
ment.26 Any disagreements on inclusion or exclusion of 
any article will be referred to a third reviewer authorised 
to resolve any disagreements for inclusion of articles. A 
PRISMA flow diagram will be presented to describe the 
study selection decisions made.
DATA EXTRACTION AND QUALITY ASSESSMENT
Conducting a quality assessment may determine the 
inclusion or exclusion of an initially selected study, and 
this should consider the robustness (validity and reli-
ability) of findings of a particular study.28 We will create a 
data extraction matrix in Microsoft Excel to capture study 
characteristics and outcomes data, such as author(s), 
study year and duration, publication year, geograph-
ical location, target population, sample, purpose, study 
design, intervention, data collection and analyses, 
outcomes, results, limitations and conclusions. Only the 
data reported in the articles will be extracted and used in 
the quality assessment although additional information 
may be sought from authors for clarification.
DATA ANALYSIS/SYNTHESIS: ASSESSMENT OF EVIDENCE 
USING THE GRADING OF RECOMMENDATIONS ASSESSMENT, 
DEVELOPMENT AND EVALUATION SYSTEM
The two primary review authors will independently 
assess the selected articles using the Grading of Recom-
mendations Assessment, Development and Evaluation 
considerations to downgrade or upgrade the certainty of 
evidence on the interventions and the specific outcomes 
reported by each study. Independent conclusions will be 
drawn on how the interventions compare to each other, 
on the specified treatment outcomes considering the esti-
mates of effects, and the certainty of the evidence (risk 
of bias, confidence in evidence/consistency in effects, 
quality of evidence, imprecision, indirectness and publi-
cation bias).31 32 The quality of evidence and risk of bias 
for non- RCTs will be assessed using the Critical Appraisal 
Skills Programme Checklist and the Risk of Bias in Non- 
randomised Studies of Interventions (ROBINS- I) Assess-
ment Tool, respectively.33 Studies which included clinical 
or medication issues such as drug resistance, and not 
necessarily adherence and retention challenges only, may 
be considered with appropriate justifications, especially 
reports on recent improved ART regimens.
We will conduct a meta- analysis only if the interventions, 
research questions or focus, and study participants allow 
for a meaningful meta- analysis. If possible, we will analyse 
results from the review by mode of infection among the 
adolescents included in meta- analysis. The meta- analysis 
will be conducted using Stata Statistical Software: Release 
V.16 (StataCorp). The χ2 test and the Higgins I² statistic 
will be used to quantify statistical heterogeneity by esti-
mating the variability between study estimates, with I² 
statistic values of 25%, 50% and 75% representing low, 
medium and high heterogeneity, respectively.34 Forest 
plots will be used to visualise the extent of heterogeneity 
or homogeneity among the selected studies.
Publication bias described as the tendency by authors 
to report positive findings, will be presented and visual-
ised on a funnel plot, as well as statistically assessed using 
the Harbord’s regression test to assess the asymmetry of 
the funnel plot.35 36 The contour- enhanced funnel plot 
will be used to distinguish between asymmetry caused 
by publication bias versus other causes, which may not 
have been successfully accomplished by the standard 
method.37 If it is not possible to do a meta- analysis, the 
findings extracted onto the Excel spreadsheet described 
above will be summarised and reported in a table form 
presenting key components of the studies. Subgroup 
analysis may include facility versus community- based 
interventions and younger versus older adolescents.
PATIENT AND PUBLIC INVOLVEMENT
No patients or public population is involved in the devel-
opment and conducting of this study, as this is a protocol 
for a systematic review of already available literature.
ETHICS AND DISSEMINATION
The systematic review entails abstracting and reviewing 
already publicly available data rather than any involve-
ment of participants, therefore, no ethical clearance or 
approval will be required.
We plan to share results of this review with relevant 
policy- makers and guidelines developers, programme 
managers and service providers, particularly providing 
evidence- based guidance for interventions targeting 
unsuppressed adolescents. We also plan to publish the 
results of the review, as well as sharing the findings with 
key stakeholders using platforms such as conferences, 
and presentations through webinars and the HIV Project 
Extension for Community Health Outcomes.38
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